Oncology & Cancer

New multimodal signature could predict immunotherapy success

An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC) and the Department of Molecular Biology has derived a molecular signature from tumor transcriptomics data that quantifies ...

Oncology & Cancer

New work validates targets for personalized cancer immunotherapy

What are the characteristics of a cancer cell that are recognized by the immune system? Knowledge of the potential target structures for the immune cells is a basic prerequisite for the development of personalized cancer ...

Oncology & Cancer

Targeting cancer with precision: Neoantigen vaccines show promise

The saga of cancer treatment is marked by a relentless pursuit of effectiveness against a disease characterized by complexity and adaptability. While immunotherapy has opened new frontiers, the challenges posed by tumor diversity ...

Oncology & Cancer

Tpex cells: A game-changer in targeted tumor immunotherapy

Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ability to self-renew and rapidly proliferate. These cells have shown promise in expanding and differentiating ...

Oncology & Cancer

Drug bypasses suppressive immune cells to unleash immunotherapy

By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer patients. However, only about one in five people responds favorably to these treatments.

page 1 from 40